Select Page
Eagle Receives USPTO Additional Patent for Bendamustine

Eagle Receives USPTO Additional Patent for Bendamustine

Eagle Pharmaceuticals have been granted their U.S. Patent No. 11,103,483 titled, “Formulations of Bendamustine”, by the U.S. Patent and Trademark Office (USPTO). Eagle plans to submit this patent to be included in the FDA’s (Food and Drug Administration’s) Orange Book...
Pfizer COVID-19 Vaccine Received Full FDA Approval

Pfizer COVID-19 Vaccine Received Full FDA Approval

Marketed under the name, Comirnaty, The US FDA (Food and Drug Administration) granted the Pfizer-BioNTech COVID-19 vaccine full approval yesterday, the first COVID-19 vaccine to become fully licensed in the US. In the US, the vaccine is now approved for people aged 16...